Share this article
Share this article
ResearchAndMarkets.com s offering.
The global glaucoma therapeutics market grew at a CAGR of around 4% during 2014-2019. Glaucoma therapeutics refers to various treatment alternatives for primary open-angle (POA) and primary angle-closure (PAC) glaucoma. The disease is characterized by structural changes in the optic nerves that usually lead to visual loss and blindness. The treatment for glaucoma can be initiated through topical eye drops, which majorly consist of beta-blockers, prostaglandin analogs, cholinergic, carbonic anhydrase inhibitors and alpha-adrenergic agonists. These eye drops minimize the production of fluid in the eyes, thereby reducing the intraocular pressure (IOP). This can be followed by traditional or laser surgical procedures or a combination of both, which use products such as implantable extended-release devices, polymer-based contact lenses, drug-eluting punctal plugs, microneedle-injection devices and micro-dosing tec
We re #33!: TSX ekes out gain in pandemic-ravaged 2020
Ian Vandaelle, BNN Bloomberg VIDEO SIGN OUT
2020 will go down in financial market history as one of the most dramatic years on record.
The global pandemic prompted unprecedented lockdowns, a tsunami of fiscal and monetary stimulus, and the most volatile swings on equity markets in a generation. Torontoâs benchmark S&P/TSX Composite Index plunged 37 per cent from peak to trough, then clawed its way back to post a 2.17 per cent gain in 2020. Thatâs good for 33rd out of 92 major global indices, with the TSX sandwiched between Malaysia and Norway in terms of total 2020 returns, but badly lagging the 16 per cent return on the S&P 500 as surging tech stocks turbocharged the bounceback south of the border.
| Press Release
Global Contact Lenses Market to 2025 with Essilor International, Novartis, Bausch Health Companies , Zeiss Group, and The Cooper Companies Dominating
ResearchAndMarkets.com s offering. The growth of the contact lens market is due to the increasing prevalence of optical disorders, increasing tendency to enhance aesthetics, and increasing disposable incomes.
Corrective Contact Lenses are Expected to Exhibit the Fastest Growth Rate over the Forecast Period
Corrective lenses refer to lenses that have been made specifically to match the wearer s defects of vision. The purpose of the corrective lens is to correct or improve the vision of people with nearsightedness (myopia), farsightedness (hyperopia), presbyopia, and astigmatism.
Toxoid Vaccines Market Next Big Thing | Major Giants Merck, Pfizer, Bharat Biotech International newyorktelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newyorktelegraph.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
LAVAL, QC, Dec. 30, 2020 /CNW/ Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health ), today announced that the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland has granted an additional new indication for DEXAVEN (dexamethasone phosphate) solution for injection, 4 mg/ml, for the treatment of COVID-19 in adult and adolescent patients (12 years of age and older weighing at least 40 kg) who require oxygen therapy. DEXAVEN is a corticosteroid that reduces inflammation. We re pleased that Poland s Office for Registration of Medicinal Products, Medical Devices and Biocidal Products has approved DEXAVEN for the treatment of symptoms due to COVID-19, because now patients in Poland have another treatment option to fight this virus, said Thomas J. Appio, president, Bausch + Lomb/International, Bausch Health. Bausch Health continues to evaluate our health care products and medicines around